Table 2.
Annual cervical cancer screening test use in the study population by age group and modality, 2013–2019.
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Percent changea | P for trend | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total | 9,828,405 | 8,916,074 | 8,445,231 | 8,437,170 | 7,947,718 | 7,422,148 | 6,879,860 | |||
| Age group, y | ||||||||||
| <18 | Cytology alone | 0.39% | 0.26% | 0.19% | 0.14% | 0.11% | 0.09% | 0.07% | −81% | <0.0001 |
| Cotesting | 0.08% | 0.06% | 0.05% | 0.04% | 0.03% | 0.03% | 0.02% | −67% | <0.0001 | |
| HPV testing alone | 0.007% | 0.007% | 0.005% | 0.004% | 0.005% | 0.006% | 0.005% | −33% | 0.017 | |
| 18–20 | Cytology alone | 11.64% | 7.02% | 8.97% | 8.45% | 8.18% | 7.80% | 7.52% | −35% | <0.0001 |
| Cotesting | 1.97% | 1.65% | 1.56% | 1.49% | 1.44% | 1.39% | 1.38% | −30% | <0.0001 | |
| HPV testing alone | 0.073% | 0.082% | 0.065% | 0.059% | 0.062% | 0.055% | 0.048% | −34% | 0.25 | |
| 21–24 | Cytology alone | 30.82% | 29.16% | 27.51% | 26.92% | 27.04% | 26.15% | 25.93% | −16% | <0.0001 |
| Cotesting | 4.67% | 4.11% | 4.15% | 4.18% | 4.06% | 4.19% | 4.19% | −10% | 0.27 | |
| HPV testing alone | 0.095% | 0.160% | 0.104% | 0.097% | 0.074% | 0.074% | 0.073% | −23% | 0.035 | |
| 25–29 | Cytology alone | 38.34% | 34.73% | 32.25% | 30.46% | 29.12% | 27.72% | 27.01% | −30% | <0.0001 |
| Cotesting | 7.83% | 7.44% | 7.73% | 7.95% | 8.16% | 8.07% | 7.76% | −1% | 0.21 | |
| HPV testing alone | 0.120% | 0.310% | 0.296% | 0.331% | 0.148% | 0.146% | 0.145% | 21% | 0.49 | |
| 30–39 | Cytology alone | 21.63% | 17.96% | 15.35% | 13.22% | 11.57% | 9.94% | 8.91% | −59% | <0.0001 |
| Cotesting | 20.12% | 20.36% | 21.02% | 22.28% | 22.88% | 23.12% | 23.68% | 18% | <0.0001 | |
| HPV testing alone | 0.244% | 0.332% | 0.377% | 0.530% | 0.417% | 0.445% | 0.460% | 89% | 0.014 | |
| 40–49 | Cytology alone | 19.64% | 16.82% | 14.41% | 12.65% | 11.25% | 9.78% | 8.99% | −54% | <0.0001 |
| Cotesting | 16.76% | 16.90% | 17.84% | 19.07% | 19.81% | 20.11% | 21.13% | 26% | <0.0001 | |
| HPV testing alone | 0.194% | 0.227% | 0.273% | 0.421% | 0.362% | 0.339% | 0.384% | 99% | 0.003 | |
| 50–64 | Cytology alone | 17.14% | 14.73% | 12.89% | 11.46% | 10.18% | 8.84% | 8.25% | −52% | <0.0001 |
| Cotesting | 11.29% | 11.63% | 12.59% | 13.66% | 14.51% | 14.77% | 15.67% | 39% | <0.0001 | |
| HPV testing alone | 0.144% | 0.153% | 0.206% | 0.310% | 0.266% | 0.249% | 0.319% | 122% | 0.0006 | |
| ≥65 | Cytology alone | 3.59% | 3.01% | 2.69% | 2.52% | 2.15% | 2.48% | 2.81% | −22% | 0.005 |
| Cotesting | 0.73% | 0.67% | 0.77% | 0.80% | 0.71% | 1.01% | 1.23% | 70% | 0.002 | |
| HPV testing alone | 0.044% | 0.039% | 0.035% | 0.025% | 0.025% | 0.029% | 0.036% | −18% | 0.019 | |
a
Calculated by subtracting the rate in 2019 from that in 2013 and dividing the result by the rate in 2013, and times 100.